3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Prostatic Neoplasms
2
Polycystic Ovary Syndrome
2
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Stomatitis
1
Precancerous Conditions
1
Papillomavirus Infections
1
Pain
1
Leukemia
1
Infections
1
Healthy
1
Fatty Liver
1
Colorectal Neoplasms
1
Interventions
Colposcopy
13
Imiquimod
12
Conization
11
Papillomavirus Vaccines
8
Cryotherapy
6
Vaccines
5
Papanicolaou Test
4
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
4
Acetic Acid
4
Watchful Waiting
3
Vaginal Smears
3
Surveys and Questionnaires
3
Biopsy
3
human papillomavirus vaccine, L1 type 16, 18
2
Spectrometry, Fluorescence
2
Proflavine
2
Mass Screening
2
Immunohistochemistry
2
Human Papillomavirus DNA Tests
2
High-Throughput Screening Assays
2
Flow Cytometry
2
Curcumin
2
Blood Specimen Collection
2
pembrolizumab
1
nimotuzumab
1
lime
1
human papillomavirus vaccine, TA
1
hecolin
1
efineptakin alfa
1
Zoledronic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Uterine Cervical Dysplasia
×
Olive Oil
×
Clear all
NCT02346227
2018-10-12
KINVAV
Universiteit Antwerpen
Phase 3
Completed
327 enrolled